Figure 2.
Univariate regression analysis between the change in IGF-I and the change in ViPCr over 12 months among all subjects with available MRS scans. □, placebo-treated subjects (n = 11); ●, tesamorelin-treated subjects (n = 9).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.